The U.S. government agency Health Resources & Services Administration warned Sanofi about facing sanctions for changing payment methods in the 340B Drug Discount Program. The agency stated that Sanofi could be terminated from the program if it proceeds with the changes without approval from the Department of Health and Human Services. Sanofi planned to provide credits to certain hospitals in the program for medicines ordered at full price, but these credits would only be issued after submitting specific claims data. The agency instructed Sanofi to halt its plans immediately to avoid potential sanctions.
Source link
Feds threaten Sanofi over proposed 340B changes
